Back

The receptor for advanced glycation end products and its ligands modulate cardiovascular cell apoptosis in diabetic patients

25 May 2019 (08:30 - 17:30)
Organised by:
Congress Presentation Part of: Poster Session 1 - Risk factors and prevention Diabetes and the Heart HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor James Tsoporis

St. Michael's Hospital, Toronto (Canada)

11 More presentations in this session

Presentation thumbnail
Doctor C. Chandramouli (Singapore, SG)
Abstract
Presentation thumbnail
Doctor J. Uzokov (Tashkent, UZ)
Abstract
Presentation thumbnail
Associate Professor M. Vizir (Kharkiv, UA)
Abstract Slides
Presentation thumbnail
Assistant Professor N. Suthahar (Rotterdam, NL)
Presentation thumbnail
Professor H. Chen (Rochester, US)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Risk factors and prevention

The Event

Event poster

Heart Failure 2019

25 May 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Single-nuclei sequencing of diabetic cardiomyopathy mouse reveals extent of immune activation and modulated by sacubitril/valsartan
21 May 2023
thumbnail
Congress Presentation
The effect of a diet reduction in advanced glycation end products on metabolic markers in patients with chronic coronary artery disease and type 2 diabetes.
29 August 2025
thumbnail
Congress Presentation
Hemoglobin glycation index and in-hospital mortality after acute myocardial infarction in patients with/without diabetes: a prospective, nationwide, and multicenter registry
31 August 2025
thumbnail
Congress Presentation
Circulating LIGHT/TNFSF14 levels are negatively associated with cardiovascular mortality, while intra-plaque levels are associated with symptomatic cerebrovascular disease
13 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources